Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

Omeros (NASDAQ:OMER – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Monday, April 7th. Analysts expect Omeros to post earnings of ($0.71) per share ...

Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid ...

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program ...

SEATTLE - Omeros Corporation (NASDAQ:OMER), a biopharmaceutical company with a market capitalization of $377 million, has announced the formation of a clinical steering committee to propel its ...

SEATTLE (AP) — SEATTLE (AP) — Omeros Corporation (OMER) on Monday reported a loss of $31.4 million in its fourth quarter. The Seattle-based company said it had a loss of 54 cents per share. Losses, ...

Pre-earnings options volume in Omeros (OMER) is 2.2x normal with calls leading puts 6:5. Implied volatility suggests the market is anticipating ...

Needham analyst Serge Belanger maintained a Hold rating on Omeros (OMER – Research Report) today. The company’s shares opened today at ...

SEATTLE - Omeros Corporation (NASDAQ:OMER), a biopharmaceutical company with a market capitalization of $377 million, has announced the formation of a clinical steering committee to propel its OncotoX ...